Go Back   Ultimate Nurse > Specialty Nurse Forums > Specialty Nursing Discussion Forum > Dialysis-Renal -Urology Nursing
Register
Connect with Facebook

Notices

Dialysis-Renal -Urology Nursing Dialysis Nurses discuss issues related to their specialty.

Reply
 
LinkBack Thread Tools Search this Thread Display Modes
Old 07-01-2008, 10:15 PM   #1
Administrator
 
cougarnurse's Avatar
 
Join Date: Oct 2006
Posts: 7,313
Mood:
Send a message via Yahoo to cougarnurse
New iron drug improves anemia with kidney disease

Anyone see this used in their practice yet? MedlinePlus: New iron drug improves anemia with kidney disease

NEW YORK (Reuters Health) - Treatment with ferumoxytol, a new iron drug that is given intravenously, is more effective against anemia than standard iron therapy, which is given by mouth, in patients with chronic kidney disease, results of a new study indicate.
Anemia, which typically involves symptoms of fatigue and weakness, is common in patients with chronic kidney disease and usually relates to decreased production of a chemical that stimulates the production of red blood cells. In some patients, however, low iron levels may be a contributing factor.
In the present study, Dr. Annamaria Krausz, at Tufts-New England Medical Center in Boston, and colleagues assessed the outcomes of 304 patients with kidney disease and anemia who were randomly assigned to receive two ferumoxytol doses given within 1 week or daily oral iron therapy for 21 days. About 40 percent of the subjects were also taking drugs designed to stimulate red blood cell production.
Compared with oral iron therapy, treatment with ferumoxytol produced a greater increase in blood levels of hemoglobin, indicating that the drug was more effective in treating anemia. Moreover, ferumoxytol was well tolerated and less likely to cause side effects than oral iron therapy.
Given its effectiveness, ferumoxytol may help patients reduce their dosage of red blood cell-stimulating drugs or avoid these agents all together.
The study findings will appear in an upcoming issue of the Journal of the American Society of Nephrology.
According to a press statement, AMAG Pharmaceuticals has submitted these trial results to the US Food and Drug Administration as part of a New Drug Application seeking marketing approval for ferumoxytol to treat iron deficiency anemia in patients with chronic kidney disease.
SOURCE: Journal of the American Society of Nephrology, August 2008.
cougarnurse is offline   Reply With Quote
Old 07-02-2008, 09:04 PM   #2
Member
 
Join Date: Apr 2007
Posts: 105
Re: New iron drug improves anemia with kidney disease

Quote:
Originally Posted by cougarnurse View Post
Anyone see this used in their practice yet? MedlinePlus: New iron drug improves anemia with kidney disease

NEW YORK (Reuters Health) - Treatment with ferumoxytol, a new iron drug that is given intravenously, is more effective against anemia than standard iron therapy, which is given by mouth, in patients with chronic kidney disease, results of a new study indicate.
Anemia, which typically involves symptoms of fatigue and weakness, is common in patients with chronic kidney disease and usually relates to decreased production of a chemical that stimulates the production of red blood cells. In some patients, however, low iron levels may be a contributing factor.
In the present study, Dr. Annamaria Krausz, at Tufts-New England Medical Center in Boston, and colleagues assessed the outcomes of 304 patients with kidney disease and anemia who were randomly assigned to receive two ferumoxytol doses given within 1 week or daily oral iron therapy for 21 days. About 40 percent of the subjects were also taking drugs designed to stimulate red blood cell production.
Compared with oral iron therapy, treatment with ferumoxytol produced a greater increase in blood levels of hemoglobin, indicating that the drug was more effective in treating anemia. Moreover, ferumoxytol was well tolerated and less likely to cause side effects than oral iron therapy.
Given its effectiveness, ferumoxytol may help patients reduce their dosage of red blood cell-stimulating drugs or avoid these agents all together.
The study findings will appear in an upcoming issue of the Journal of the American Society of Nephrology.
According to a press statement, AMAG Pharmaceuticals has submitted these trial results to the US Food and Drug Administration as part of a New Drug Application seeking marketing approval for ferumoxytol to treat iron deficiency anemia in patients with chronic kidney disease.
SOURCE: Journal of the American Society of Nephrology, August 2008.
I've been in HD since the late 80's. We've been telling dialysis patients not to take oral iron ever since I started HD. Nothing new to that. They can't metabolize oral iron. We started with Infed, went to Ferrlicet, and now Venofer.
The "chemical" ESRD patients lack is a hormone secreted by the kidneys that tells the bone marrow to produce red blood cells.

Venofer has been given for >30 years without any deaths associated with it. A safe drug. Works well, doesn't need to be held for monthly labs, proven effective in helping lower Epogen doses. No test dose needed.

No need for a new drug.
onetraveler is offline   Reply With Quote
Old 02-10-2009, 07:26 AM   #3
Registered User
 
Join Date: Jan 2009
Posts: 1
What is its exact effect on Anemia Disease?
bigllama37 is offline   Reply With Quote
Reply

Go Back   Ultimate Nurse > Specialty Nurse Forums > Specialty Nursing Discussion Forum > Dialysis-Renal -Urology Nursing
 
 
  • Submit Thread to Digg Digg
  • Submit Thread to del.icio.us del.icio.us
  • Submit Thread to StumbleUpon StumbleUpon
  • Submit Thread to Google Google
  • Bookmarks

    Thread Tools Search this Thread
    Search this Thread:

    Advanced Search
    Display Modes



    Similar Threads
    Thread Thread Starter Forum Replies Last Post
    FDA expands warning on anti-anemia drugs cougarnurse Medication alerts and discussion 0 03-10-2008 02:17 AM
    Iron sharpening iron The unexplainable Moo Cow General Nursing Discussion 1 11-05-2006 04:05 PM
    Software to Help in Sickle Cell Anemia nursebot Nursing News 0 09-15-2006 10:59 PM
    Hospitalized hunter's condition improves nursebot Nursing News 0 09-06-2006 12:59 PM
    Hopsital News - Iron Mountain Helps PinnacleHealth Improve Patient Service Levels and Physician Satisfaction While Reducing Co nursebot Nursing News 0 03-06-2006 10:59 AM



    Invite your friends from Facebook, MySpace, Twitter, and tons of other social networks.
    Click Here to Begin!

    1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134